Amgen Inc. ( AMGN) - Stock Earnings
AMGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 3.2 billion USD | 9.6 billion USD |
| 2025Q4 | 1.3 billion USD | 9.9 billion USD |
| 2026Q1 | 1.8 billion USD | 8.6 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AMGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.7 billion USD | 28.2 billion USD |
| 2024 | 4.1 billion USD | 33.4 billion USD |
| 2025 | 7.7 billion USD | 36.7 billion USD |
| 2026 Est. | — | — |
AMGN
List: Contenders
Price: $355.20
Dividend Yield: 2.88%
Forward Dividend Yield: 2.84%
Payout Ratio: 155.17%
Dividend Per Share: 10.08 USD
Earnings Per Share: 14.37 USD
P/E Ratio: 23.04
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 1.7 million
Ebitda: 3.6 billionMarket Capitalization: 188.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 16
DGR3: 7.77%
DGR5: 8.72%
DGR10: 12.87%